CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 155 enrolled
Drug / intervention
Flovent Diskus +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02251379
NCT02251379Phase 2Completed
CompareCT.gov

Environmental Control as Add-on Therapy in Childhood Asthma

Johns Hopkins University·interventional·Posted Sep 29, 2014·Updated Nov 20, 2019

In Brief

A Phase 2 clinical trial evaluating Flovent Diskus, Home Environmental Intervention, and 1 other intervention for Asthma. Completed, enrolled 155 participants across 1 site.

Detailed Summary

This study evaluates the effects of adding on an environmental home intervention to standard asthma medication management on controller medication requirements among children and adolescents with asthma. The investigators hypothesize that the addition of an individually-tailored, multi-faceted Environmental Control Strategy (ECS) to guidelines-based controller medication will result in less controller medication requirement and allergic inflammation than controller medication alone among urban asthmatic children.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
201520162017201820192020202120222023202420252026
First PostedSep 29, 2014
Enrollment StartOct 1, 2014
Primary CompletionNov 1, 2018
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 11.8 years ago

Interventions

Flovent Diskusdrug

Inhaled corticosteroids

Home Environmental Interventionother

Mouse, Cockroach, Furry pets, Dust mites, Smoking, air purifiers, laundered bedding

Advair Diskusdrug

inhaled corticosteroids + long-acting beta agonist